Logo image of FRSH.CA

THE FRESH FACTORY BC LTD (FRSH.CA) Stock Fundamental Analysis

TSX-V:FRSH - TSX Venture Exchange - CA35805H1055 - Common Stock - Currency: CAD

0.97  +0.04 (+4.3%)

Fundamental Rating

1

Overall FRSH gets a fundamental rating of 1 out of 10. We evaluated FRSH against 0 industry peers in the Unkown industry. FRSH has a bad profitability rating. Also its financial health evaluation is rather negative. FRSH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FRSH had negative earnings in the past year.
In the past year FRSH had a positive cash flow from operations.
FRSH.CA Yearly Net Income VS EBIT VS OCF VS FCFFRSH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -6.37%
ROE -16.86%
ROIC N/A
ROA(3y)-41.05%
ROA(5y)N/A
ROE(3y)-73.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRSH.CA Yearly ROA, ROE, ROICFRSH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 50 -50

1.3 Margins

FRSH's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for FRSH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.9%
GM growth 5YN/A
FRSH.CA Yearly Profit, Operating, Gross MarginsFRSH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 -40

More info and screens

1

2. Health

2.1 Basic Checks

FRSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
FRSH has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, FRSH has a worse debt to assets ratio.
FRSH.CA Yearly Shares OutstandingFRSH.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M 50M
FRSH.CA Yearly Total Debt VS Total AssetsFRSH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -0.12, we must say that FRSH is in the distress zone and has some risk of bankruptcy.
FRSH has a debt to FCF ratio of 4.00. This is a neutral value as FRSH would need 4.00 years to pay back of all of its debts.
FRSH has a Debt/Equity ratio of 0.55. This is a neutral value indicating FRSH is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4
Altman-Z -0.12
ROIC/WACCN/A
WACC8.18%
FRSH.CA Yearly LT Debt VS Equity VS FCFFRSH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M

2.3 Liquidity

A Current Ratio of 1.05 indicates that FRSH should not have too much problems paying its short term obligations.
FRSH has a Quick Ratio of 1.05. This is a bad value and indicates that FRSH is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.78
FRSH.CA Yearly Current Assets VS Current LiabilitesFRSH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.83% over the past year.
Looking at the last year, FRSH shows a very strong growth in Revenue. The Revenue has grown by 32.76%.
FRSH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.30% yearly.
EPS 1Y (TTM)77.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.83%
Revenue 1Y (TTM)32.76%
Revenue growth 3Y41.3%
Revenue growth 5YN/A
Sales Q2Q%41.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRSH.CA Yearly Revenue VS EstimatesFRSH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 5M 10M 15M 20M
FRSH.CA Yearly EPS VS EstimatesFRSH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FRSH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRSH.CA Price Earnings VS Forward Price EarningsFRSH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.05
EV/EBITDA 26.95
FRSH.CA Per share dataFRSH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FRSH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

THE FRESH FACTORY BC LTD

TSX-V:FRSH (3/7/2025, 7:00:00 PM)

0.97

+0.04 (+4.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.97%
Ins Owner ChangeN/A
Market Cap10.14M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF 5.05
P/OCF 3.63
P/B 1.27
P/tB 1.27
EV/EBITDA 26.95
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.19
FCFY19.81%
OCF(TTM)0.27
OCFY27.52%
SpS4.13
BVpS0.76
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.37%
ROE -16.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.77%
FCFM 4.65%
ROA(3y)-41.05%
ROA(5y)N/A
ROE(3y)-73.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.9%
GM growth 5YN/A
F-Score6
Asset Turnover2.05
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 4
Debt/EBITDA 7.57
Cap/Depr 38.44%
Cap/Sales 1.81%
Interest Coverage N/A
Cash Conversion 479.66%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.78
Altman-Z -0.12
F-Score6
WACC8.18%
ROIC/WACCN/A
Cap/Depr(3y)119.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.75%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.76%
Revenue growth 3Y41.3%
Revenue growth 5YN/A
Sales Q2Q%41.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y76.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y119.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y141.68%
OCF growth 3YN/A
OCF growth 5YN/A